Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study. - Vassy JL; Dornisch AM; Karunamuni R; Gatzen M; Kachulis CJ; Lennon NJ; Brunette CA; Danowski ME; Hauger RL; Garraway IP; Kibel AS; Lee KM; et al. (Nature cancer, 2026)